Serotonin transporter polymorphisms

Ng, C. H., Easteal, S., Tan, S. et al. (2006b). Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities. Progress in Neuropsychopharmacology and Biological... 

Durham, L. K., Webb, S. M., Milos, P. M., Clary, C. M. Seymour, A. B. (2004). The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology, 174, 525-9. 

CamiUeri, M., Atanasova, E., Carlson, P. J., et al. (2002) Serotonin-transporter polymorphism. Pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 123, 425 32. 

Kendlei K. S., Kuhn, J. W, Vittum, J., Prescott, C. A., Riley, B. (2005). The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Archives of General Psychiatry, 62, 529-535. 

Keywords Dopamine transporter Norepinephrine transporter Serotonin transporter Polymorphism Attention deficit h5rperactivity disorder Parkinson s disease Addiction Anxiety Depression Autism... 

Roberts KE, Fallon MB, Krowka MJ, et al. Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest 2009 135(6) 1470-5. 

Popp J, Leucht S, Heres S, Steimer W (2006). Serotonin transporter polymorphisms and side effects in antidepressant therapy—a pilot study. Pharmacogen. 7 159-166. 

Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost 2008 6(12) 2168-74. 

Arias, B., Catalan, R. et al. (2003). 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. /. Clin. Psychopharmacol, 23(6), 563-7. 

Smeraldi, E., Zanardi, R. et al. (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry, 3(6), 508-11. Wang, S. L., Huang, J. D. et al. (1993). Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects polymorphism in RFLP and DNA sequence of CYP2D6. Clin. Pharmacol. Ther., 53(4), 410-18. 

Yoshida, K., Ito, K. etal. (2002). Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26(2), 383-6. 

Yu, Y. W., Tsai, S. J. etal. (2002). Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol. Psychiatry, 7(10), 1115-19. 

Kim, D.K.et al. (2000). Serotonin transporter gene polymorphism and antidepressant response. Neuroreport, 11,215-19. 

Smeraldi, E. et al. (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry, 3, 508-11. 

Lesch, K. P., Bengel, D., Heils, A. etal. (1996). Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527-31. 

Minov, C., Baghai, T.C., Schule, C. etal. (2001). Serotonin-2A-receptor and -transporter polymorphisms lack of association in patients with major depression. Neurosci. Lett., 303, 119-22. 

Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M. Smeraldi, E. (2000). Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. /. Clin. Psychopharmacol., 20, 105-7. 

Wang, X. X., Mu, J. S. Wang, S. H. (2004). Association study of serotonin transporter gene polymorphism and depression. Chinese Journal of Clinical Psychiatry, 14(4), 195-7. 

Serretti, A., Benedetti, F., Zanardi, R. Smeraldi, E. (2005). The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog. Neuro psychopharmacol. Biol. Psychiatry, 29(6), 1074-84. 

---